marc_p2

Mundipharma names Marc Princen as Global Chief Executive Officer

June 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment

Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …

covid-19-4922384_640

COVID-19: UK and Europe life sciences regulatory developments

June 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation

Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …

janssen_latest_logo_on_sign_closer

Tremfya’s skin clearance benefit lasts up to four years in plaque psoriasis patients, Janssen says

June 15, 2020
Research and Development, Sales and Marketing Janssen, Tremfya, plaque psoriasis

Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual …

wuhan_citiy

Fear of a coronavirus second wave as China reports highest number of cases in months

June 15, 2020
Sales and Marketing COVID, COVID-19, coronavirus, pandemic

China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …

az_vaccinessssssssssss

AstraZeneca to supply Europe with 400 million COVID-19 vaccine doses

June 15, 2020
Sales and Marketing COVID, COVID-19, Vaccine, coronavirus

Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …

NICE greenlights Roche’s Rozlytrek for ROS1+ advanced non-small cell lung cancer

June 15, 2020
Sales and Marketing NICE, Roche, Rozlytrek, UK, lung cancer

Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …

mr_robot_cancer

AbbVie’s Venclexta plus azacitidine shows improved survival and remissions rates in leukaemia patients

June 15, 2020
Sales and Marketing AbbVie, leukaemia

AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission …

shutterstock_138095450

Takeda jettisons non-core portfolio in Asia Pacific to Celltrion for a potential $278 million

June 12, 2020
Medical Communications, Sales and Marketing Takeda, celltrion, pharma, sale

Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …

vaccinessssss

Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in July

June 12, 2020
Medical Communications COVID-19, coronavirus

Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials. The …

fda2outsideweb

Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes

June 12, 2020
Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes

Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …

top_10_image_2_3

Top Ten most popular articles on Pharmafile.com this week

June 12, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing coronavirus, top 10

The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the …

nhs_docttttttt

Coronavirus has caused widespread disruption to cancer care in England

June 12, 2020
Medical Communications COVID-19, coronavirus

Figures show that cancer care in England has faced major disruption due to a big drop in referrals from GPs …

mdma

Study finds that MDMA has long-term benefits for treating PTSD

June 11, 2020
Business Services MDMA, PTSD

PTSD patients being treated with MDMA experience numerous beneficial effects that hold strong for well after a year after completing …

merck-keytruda

MSD’s Keytruda misses the mark at Phase 3 in advanced bladder cancer

June 11, 2020
Research and Development MSD< Keytruda, bladder cancer, pharma, trial failure

MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with chemotherapy, …

eli_lilly

Eli Lilly’s coronavirus antibody treatments could be available by September

June 11, 2020
Business Services COVID, COVID-19, coronavirus

An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its …

shutterstock_273326141

AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn

June 11, 2020
Research and Development AbbVie, Genmab, partnership, pharma

AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …

Leading pharmaceutical companies sued in US for conspiring to drive up generics prices

June 11, 2020
Business Services drugs, generics, lawsuit, price fixing, price-fixing

26 pharmaceutical companies are being sued by most US states for allegedly conspiring to reduce competition and drive up generic …

capture

How digital therapeutics are revolutionising healthcare

June 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital therapeutics, feature, pharma

Digital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …

cedrik_britten

Ex-GSK exec named as Chief Medical Officer at Immatics Biotechnologies

June 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment, immatics

Immatics Biotechnologies welcomed former GlaxoSmithKline executive Dr Cedrik Britten to the company as its new Chief Medical Officer (CMO) on …

nhsyyy

Number of people waiting for NHS treatment could double to 10 million due to pandemic

June 10, 2020
Research and Development COVID-19, coronavirus

The backlog of people waiting for treatment on the NHS could reach as high as 10 million people by Christmas …

The Gateway to Local Adoption Series

Latest content